Improvements to tiny body-on-a-chip devices could lead to next-generation pre-clinical testing of drug toxicity
Researchers at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) in Japan have designed a small ‘body-on-a-chip’ device that can test the side effects of drugs s on human cells. The device solves some issues with current, similar microfluidic devices and offers promise for the next generation of pre-clinical drug tests.
The Integrated Heart/Cancer on a Chip (iHCC) was used to test the toxicity of the anti-cancer drug doxorubicin on heart cells. The researchers, led by iCeMS’s Ken-ichiro Kamei, found that, while the drug itself was not toxic to heart cells, a metabolite of the drug resulting from its interaction with cancer cells was.
The device is smaller than a microscope glass slide. It contains six tiny chambers; every two are connected by microchannels with a series of port inlets and valves. A pneumatic pump controls movement of fluid through the channels. Every two chambers and their separate microchannel system constitute one test bed. Three test beds in the device allow for the introduction of minor changes in each bed to simultaneously compare results.
The team first tested doxorubicin’s effects on heart cells and liver cancer cells cultured separately in small wells. The drug had the expected anti-cancer effect on the cancer cells without causing damage to the heart cells.
They then ran the test using the iHCC device. Heart cells were placed in one chamber while liver cancer cells were placed in the other. Doxorubicin was introduced into a cell culture medium circulating through a closed-loop system of microchannels that connects the two chambers, mimicking the blood’s circulatory system. In this way, the drug flows unidirectionally in a continuous loop through both chambers.
The team found signs of toxicity in both cancer and heart cells. They hypothesized that a compound, doxorubicinol, which is a metabolic byproduct of doxorubicin interacting with cancer cells, was causing the toxic effect.
To test this, they added doxorubicinol to heart cells and liver cancer cells cultured separately in small wells. It was toxic to the heart cells but not to the cancer cells.
When doxorubicin alone is added to the liver cancer cells, the amount of doxorubicinol produced is too small to be toxic to the heart cells. The team believes this is because the amount of cell culture medium needed for the well-based tests dilutes the metabolite.
In contrast, when doxorubicin is introduced into the iHCC, the metabolite is not diluted when moving through the microchannel circulation system because a smaller volume of cell culture is needed. As a result, the drug does have a toxic effect on the heart cells via its metabolite.
The device requires further improvements, but the study demonstrates how this design concept could be used to investigate the toxic side effects of anti-cancer drugs on heart cells well before expensive clinical trials. The study was published in the journal Royal Society of Chemistry Advances.
Learn more: Next-generation drug testing on chips
The Latest on: Body-on-a-chip
[google_news title=”” keyword=”body-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Eating this food is worse for your teeth than candy: dental experton February 23, 2024 at 12:07 pm
Dark chocolate, on the other hand, is surprisingly good for your teeth because it can be easily rinsed off, as are foods that “require heavier biting and chewing,” such as crunchy vegetables like ...
- Developing standards for organ-on-a-chip researchon February 22, 2024 at 1:33 pm
When testing a new medicine, researchers must do more than assess how well that drug works. They also have to determine whether the medicine has some negative, unintended consequences.
- How the dead serve as bargaining chips in the Israel-Hamas conflicton February 22, 2024 at 9:06 am
Israel and Hamas are both holding the bodies of those killed on the other side, refusing to release them. They've done so for years and are again using the enemy dead as leverage in the current war.
- Wipro wins deal to design Intel’s latest chipson February 21, 2024 at 7:13 pm
Though the exact size of the deal is not disclosed, the deal will see Wipro engineers work on Intel’s latest ‘18A’ chip node that will be used in cutting-edge consumer electronics devices next year ...
- If you invested $1,000 in Nvidia 10 years ago, here’s how much money you’d have nowon February 21, 2024 at 1:52 pm
High demand for those chips has propelled the company into Wall ... to learn what hiring managers are really looking for, body language techniques, what to say and not to say, and the best way ...
- Sylvester Stallone ‘regurgitates Rocky clichés as daughters chip away at alpha male status’ in Season 2 of reality showon February 21, 2024 at 7:23 am
SYLVESTER Stallone will never relinquish his Rocky alter-ego despite his family’s efforts to enjoy the limelight in their reality series, a body language expert has said. She claimed that ...
- Mother sparks debate with ‘lettuce chips’ recipe: ‘No nutritional value’on February 20, 2024 at 3:03 pm
Kathleen Ashmore recently took to TikTok to share her recipe for “lettuce chips,” which she revealed consists of chopped up heads of romaine lettuce, which are meant to look like chips and be dipped ...
- Heart-Healthy Food Swaps With Earn That Bodyon February 20, 2024 at 10:15 am
Kim Eagle with Earn That Body joined Studio 512 with better-for-you food swaps that will keep you snacking happy during American Heart Month! Kim’s Tips: If a recipe calls for soy ...
- Forget Passwords and Badges: Your Body Is Your Next Security Keyon February 14, 2024 at 10:13 am
Biometric scanning and AI advances mean security systems could use traits from your gait to your gaze to unlock your company’s building and systems.
- Scientists unveil new 'heart-on-a-chip'on February 14, 2024 at 6:48 am
So-called heart-on-a-chip systems may enable scientists to evaluate the safety and efficacy of new drugs more accurately than they can with animal tests.
via Google News and Bing News